Nektar Therapeutics reported 0 in Dividend Yield for its fiscal quarter ending in March of 2025.





Dy Change Date
Alterity Therapeutics Limited AUD 0 0 Dec/2024
Amgen 2.95 0.38 Dec/2025
Baxter International 2.72 0.26 Dec/2025
BioCryst Pharmaceuticals 0 0 Mar/2025
Bristol-Myers Squibb 0.22 0.04 Dec/2025
Cara Therapeutics 0 0 Mar/2025
Cipla 0.86 0 Dec/2025
Dr.Reddys Laboratories 0.63 0.02 Dec/2025
Eisai 3.22 0.64 Sep/2025
Eli Lilly 0.58 0.16 Dec/2025
Esperion Therapeutics 0 0 Mar/2025
Gilead Sciences 2.58 0.25 Dec/2025
GlaxoSmithKline 4.57 1.52 Dec/2025
Grifols EUR 2.56 0.28 Jun/2022
Karyopharm Therapeutics 0 0 Mar/2025
Merck 3.12 0.74 Dec/2025
Nektar Therapeutics 0 0 Mar/2025
Novartis USD 3.31 0.06 Sep/2025
Pfizer 6.91 0.33 Dec/2025
Roche Holding 2.96 0.8 Dec/2025
Takeda 4.08 0.46 Dec/2025